Correlation Between Verizon Communications and Vertex Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verizon Communications and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verizon Communications and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verizon Communications and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Verizon Communications and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verizon Communications with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verizon Communications and Vertex Pharmaceuticals.

Diversification Opportunities for Verizon Communications and Vertex Pharmaceuticals

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Verizon and Vertex is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Verizon Communications and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Verizon Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verizon Communications are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Verizon Communications i.e., Verizon Communications and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verizon Communications and Vertex Pharmaceuticals

Assuming the 90 days horizon Verizon Communications is expected to generate 0.95 times more return on investment than Vertex Pharmaceuticals. However, Verizon Communications is 1.05 times less risky than Vertex Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest  61,070  in Verizon Communications on August 25, 2024 and sell it today you would earn a total of  26,429  from holding Verizon Communications or generate 43.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.56%
ValuesDaily Returns

Verizon Communications  vs.  Vertex Pharmaceuticals

 Performance 
       Timeline  
Verizon Communications 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Verizon Communications are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Verizon Communications may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Vertex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Verizon Communications and Vertex Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verizon Communications and Vertex Pharmaceuticals

The main advantage of trading using opposite Verizon Communications and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verizon Communications position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.
The idea behind Verizon Communications and Vertex Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences